Only show
results from:

Sort results by:

Display preferences
140 results sorted by relevancy Results per page:
Genmab and ACE BioSciences to Develop Product to Treat Fungal Infections; Identify First Target in Their Joint Development Collaboration.
PR Newswire; Nov 17, 2003; 700+ Words Genmab A/S and privately held ACE BioSciences A/S announced today that they will develop an antibody therapeutic...Genmab, visit http://www.genmab.com/. About ACE BioSciences A/S ACE BioSciences is a biotechnology company focused on...
Genmab and ACE Biosciences team to develop new drugs for infectious diseases.(Brief Article)
Nordic Business Report; May 13, 2002; 700+ Words ...NORDIC BUSINESS REPORT-13 May 2002-Genmab and ACE Biosciences team to develop new drugs for infectious diseases...com The Danish biotechnology companies Genmab A/S and ACE Biosciences A/S have agreed to collaborate on the development of...
ACE BioSciences.(Movers & shakers)(appointment of David Colpman)(Brief article)
Chemistry and Industry; Sep 29, 2008; 535 Words ACE BioSciences has appointed Shire's senior vice president of business development, David Colpman...Nordisk and Boots Pharmaceuticals prior to joining Shire. ACE BioSciences, based in Denmark, develops vaccines for serious bacterial...
Appointments And Advancements.(ACE BioSciences, Acologix Inc, Advancis Pharmaceutical Corp.)(Brief article)
BIOWORLD Today; Mar 20, 2006; 700+ Words ACE BioSciences A/S, of Odense, Denmark, appointed a vaccine...John Lachin and Mark Pescovitz. Ambit Biosciences, of San Diego, appointed Nicholas Lydon...Wendell Wierenga also joined the company's board. Anadys Pharmaceuticals Inc...
ACE BioSciences appoints Petra Schrotz-King as chief scientific officer.(vice president of drug discovery)(Brief article)
Pharma Marketletter; Jul 3, 2006; 518 Words Danish infectious-disease specialists ACE BioSciences A/S says that it has appointed Petra Schrotz-King as its...discovery, has been appointed as part of the company's preparation for the launch of its travellers diarrhea...
SAFC Biosciences and Chromos Announce Strategic Alliance to Co-Market ACE System.
PR Newswire; Oct 19, 2005; 700+ Words ...FirstCall/ -- SAFC Biosciences, a member of the Sigma...arrangement whereby SAFC Biosciences and Chromos will jointly...Chromos' proprietary ACE System for cell line...agreement adds to SAFC's process development...said Bruce Lehr, SAFC Biosciences. "Combined with SAFC...
Genmab and ACE BioSciences to Develop Product to Treat Fungal Infections.
PR Newswire; Nov 17, 2003; 700+ Words ...Collaboration - Summary: Genmab and ACE BioSciences have identified the first target...their collaboration. Genmab A/S (CSE: GEN) and privately...visit www.genmab.com. About ACE BioSciences A/S ACE BioSciences is a biotechnology company focused...
ACE BioSciences and PATH Announce New Collaboration to Develop a Vaccine Against Diarrheal Disease; Partnership Will Accelerate Development of the ACE527 Vaccine Against Enterotoxigenic Escherichia Coli (ETEC).
AScribe Medicine News Service; Jun 19, 2008; 700+ Words ...Earlier this year, ACE BioSciences and PATH...development activities ACE BioSciences will conduct under the...agreement. - - - About ACE BioSciences ACE BioSciences was founded in 2001 from Odense University's Centre of Excellence...
LION bioscience Announces Partnership with ACE BioSciences.
PR Newswire; Nov 6, 2001; 700+ Words ...Markt: LIO, WKN 504 350, Nasdaq: LEON) and ACE BioSciences A/S today announced that they have entered into...Sumitomo Pharmaceuticals and Tripos. About ACE BioSciences A/S: ACE BioSciences A/S (http://www.acebiosciences.com...
ACE BioSciences enters collaboration.
Biotech Week; Jun 12, 2002; 700+ Words ...NewsRx.net) -- Genmab A/S and the privately owned Danish based ACE BioSciences announced a collaboration...Under the agreement ACE BioSciences will provide novel commercially...Genmab will use the company's fully human antibody technology...
ACE Biosci and Nordic Vaccine enter development accord.(ACE BioSciences, Nordic Vaccine AS)(Brief Article)
Pharma Marketletter; Mar 13, 2006; 609 Words ...infectious diseases firm ACE BioSciences AS and Nordic Vaccine AS...Initial work will focus on ACE BioSciences' traveller's diarrhea vaccines. Under...delivery technologies to ACE BioSciences' products.
Gyros and ACE Biosciences team to test new sample preparation technology.(Brief Article)
Nordic Business Report; Jan 7, 2002; 613 Words ...REPORT-7 January 2002-Gyros and ACE Biosciences team to test new sample preparation...Danish biotechnology company ACE BioSciences A/S have signed a collaboration agreement...agreement a prototype of Gyros AB's first product, which is designed...
ACE BioSciences A/S-Company Report.
M2 Presswire; Jan 26, 2009; 498 Words ...January 2009-www.companiesandmarkets.com: ACE BioSciences A/S-Company Report(C)1994-2009 M2 COMMUNICATIONS...companiesandmarkets.com adds new report: ACE BioSciences A/S-Company Report Private Company Reports provide...
ACE signs production agreement with SynCo.(ACE BioSciences A/S with SynCo BioPartners )(Brief Article)
Pharma Marketletter; Mar 28, 2005; 599 Words ...focused biopharmaceutical company ACE BioSciences A/S has signed a deal with Dutch vaccines...standard production of the former's lead product, ACE 393, the first commercial vaccine for traveller's diarrhea caused by campylobacter...
ACE starts travellers' diarrhea model development study.(ACE BioSciences )(Brief article)
Pharma Marketletter; Apr 16, 2007; 700+ Words Danish drugmaker ACE BioSciences SA says it has initiated patient dosing...Investigational New Drug application. ACE explained that the program is designed...year. Ingelise Saunders, the firm's chief executive, said that, if the...
SPIN-OUT AGRISOMA FOCUSES ON ENHANCED CROPS, THERAPEUTICS.(Agrisoma Biosciences Inc.)
BIOWORLD Today; Apr 29, 2004; ; 700+ Words ...through development of its ACE System in plants, Agrisoma Biosciences Inc. closed a Series...undisclosed, the company's new president and CEO...individuals. "It's a very strong show of...Mamic said. "It's a very critical vote...
ACE's Campylobacter diarrhea vacc enters Ph IIb trial.
Pharma Marketletter; Dec 8, 2008; 700+ Words ...Odense, Denmark-based ACE BioSciences has begun a landmark Phase...with ACE393, the world's first commercial Campylobacter...is a milestone for ACE BioSciences and in the fight against...Drug Administration's current safety requirements...
ACE Bio collaborates with PATH on ETEC vacc.
Pharma Marketletter; Mar 17, 2008; 700+ Words ACE BioSciences, a Danish biotechnology company focused on vaccines...the terms of the agreement, funded under PATH's Enteric Vaccine Initiative, ACE BioSciences will collaborate with PATH's vaccine stabilization project team to develop...
ACE BioSci's Campylobacter vacc enters Ph I trial.(product development ACE393)
Pharma Marketletter; Sep 4, 2006; 654 Words Odense, Denmark-based drug developer ACE BioSciences AS says that its lead product, ACE393, the world's first commercial vaccine for diarrhea caused...infections in the developed world. The vaccine's safety, tolerability and immunogenicity...
ACE Bio collaborates on travellers' diarrhea vaccine.(Naval Medical Research Center)(traveller diarrhea caused by Campylobacter infection)(Brief article)
Pharma Marketletter; Sep 11, 2006; 700+ Words Odense, Denmark-based ACE BioSciences A/S, an infectious diseases company...groups will progress the former's lead product, ACE393, through...Campylobacter has remained elusive. ACE BioSciences recently began Phase I clinical...
140 results: 1 | 2 | 3 | 4 | 5 | Next >>

Find articles, research, and archives